Cargando…
Experimentally Induced Anti-Myeloperoxidase Vasculitis Is Not Attenuated in Factor B or VISTA Deficient Mice
BACKGROUND: Anti-neutrophil cytoplasmic antibody vasculitis is characterized by antibodies to myeloperoxidase or proteinase 3. Previous work in murine anti-myeloperoxidase vasculitis has shown a role for the alternative pathway complement component factor B and the anaphylatoxin C5a. However, mice d...
Autores principales: | Flórez-Barrós, Fernanda, Freeley, Simon J., Tham, El Li, Robson, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670022/ https://www.ncbi.nlm.nih.gov/pubmed/36751530 http://dx.doi.org/10.1159/000521233 |
Ejemplares similares
-
Phosphatidylinositol 3‐Kinase δ Deficiency Protects From Antimyeloperoxidase Vasculitis
por: Flórez‐Barrós, Fernanda, et al.
Publicado: (2022) -
Myeloid expression of the anti-apoptotic protein Mcl1 is required in anti-myeloperoxidase vasculitis but myeloperoxidase inhibition is not protective
por: Florez-Barros, Fernanda, et al.
Publicado: (2023) -
Experimentally‐induced anti‐myeloperoxidase vasculitis does not require properdin, MASP‐2 or bone marrow‐derived C5
por: Freeley, Simon J, et al.
Publicado: (2016) -
Native myeloperoxidase is required to make the experimental vasculitis model
por: Nonokawa, Mayu, et al.
Publicado: (2019) -
Pulmonary fibrosis—an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?
por: Bhanji, Amir, et al.
Publicado: (2010)